Skip to main content

Clearstead Advisors, LLC

SEC CIK
0000842775
Latest filing
Aug 6, 2026

AZN holding history

AstraZeneca PLC in every 13F filed by Clearstead Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

AZN overviewAll 13F holders of AZNFull Q2 2026 holdings

Shares (Q2 2026)
10,161
Value
$1.92M
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of AZN by Clearstead Advisors, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202610,161$1.92M<0.1%+5,778+131.8%AddedHolders
Q1 20264,383$859.9K<0.1%−656−13.0%ReducedConverted for a 1-for-2 splitHolders
Q4 202510,078$926.5K<0.1%−42−0.4%ReducedHolders
Q3 202510,120$776.4K<0.1%+591+6.2%AddedHolders
Q2 20259,529$665.9K<0.1%+1,287+15.6%AddedHolders
Q1 20258,242$605.8K<0.1%−1,420−14.7%ReducedHolders
Q4 20249,662$633.1K<0.1%−525−5.2%ReducedHolders
Q3 202410,187$793.6K<0.1%−310−3.0%ReducedHolders
Q2 202410,497$818.7K<0.1%+9,167+689.2%AddedHolders
Q1 20241,330$103.0K<0.1%+21+1.6%AddedHolders
Q4 20231,309$88.2K<0.1%+100+8.3%AddedHolders
Q3 20231,209$81.9K<0.1%+162+15.5%AddedHolders
Q2 20231,047$74.9K<0.1%−50−4.6%ReducedHolders
Q1 20231,097$76.1K<0.1%+454+70.6%AddedHolders
Q4 2022643$43.6K<0.1%00.0%UnchangedHolders
Q3 2022643$35.0K<0.1%−487−43.1%ReducedHolders
Q2 20221,130$75.0K<0.1%−482−29.9%ReducedHolders
Q1 20221,612$107.0K<0.1%+489+43.5%AddedHolders
Q4 20211,123$65.0K<0.1%−1,400−55.5%ReducedHolders
Q3 20212,523$152.0K<0.1%+1,993+376.0%AddedHolders
Q2 2021530$32.0K<0.1%+480+960.0%AddedHolders
Q1 202150$2.00K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.